669 related articles for article (PubMed ID: 30713034)
1. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
[TBL] [Abstract][Full Text] [Related]
2. β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.
Mehta S; Singh C; Plata KB; Chanda PK; Paul A; Riosa S; Rosato RR; Rosato AE
Antimicrob Agents Chemother; 2012 Dec; 56(12):6192-200. PubMed ID: 22985884
[TBL] [Abstract][Full Text] [Related]
3. Can β-Lactam Antibiotics Be Resurrected to Combat MRSA?
Foster TJ
Trends Microbiol; 2019 Jan; 27(1):26-38. PubMed ID: 30031590
[TBL] [Abstract][Full Text] [Related]
4. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
6. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.
Sharma AD; Gutheil WG
Microbiol Spectr; 2023 Feb; 11(1):e0372622. PubMed ID: 36519895
[TBL] [Abstract][Full Text] [Related]
8. Methicillin-resistant Staphylococcus aureus infections: role of daptomycin/β-lactams combination.
Leone S; Noviello S; Boccia G; De Caro F; Esposito S
Infez Med; 2015 Jun; 23(2):99-104. PubMed ID: 26110289
[TBL] [Abstract][Full Text] [Related]
9. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
Trials; 2016 Mar; 17():170. PubMed ID: 27029920
[TBL] [Abstract][Full Text] [Related]
10. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides.
Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434
[TBL] [Abstract][Full Text] [Related]
11. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
Tran N; Rybak MJ
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus.
Tsai CE; Yang CJ; Chuang YC; Wang JT; Sheng WH; Chen YC; Chang SC
Int J Infect Dis; 2022 Sep; 122():230-236. PubMed ID: 35640827
[TBL] [Abstract][Full Text] [Related]
13. Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.
Zheng X; Berti AD; McCrone S; Roch M; Rosato AE; Rose WE; Chen B
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158272
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Correlates of Enhanced Daptomycin Activity following β-Lactam Preconditioning in Daptomycin-Resistant, Methicillin-Resistant Staphylococcus aureus.
Lew C; Pellitteri Hahn M; Scarlett C; Rottier A; Berti AD; Proctor RA; Bayer AS; Rose WE
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0201721. PubMed ID: 35041502
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Molina KC; Morrisette T; Miller MA; Huang V; Fish DN
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312776
[TBL] [Abstract][Full Text] [Related]
16.
Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
Saravolatz LD; Pawlak J
J Antimicrob Chemother; 2022 Dec; 78(1):238-241. PubMed ID: 36374572
[TBL] [Abstract][Full Text] [Related]
18. Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen.
Bal AM; David MZ; Garau J; Gottlieb T; Mazzei T; Scaglione F; Tattevin P; Gould IM
J Glob Antimicrob Resist; 2017 Sep; 10():295-303. PubMed ID: 28732783
[TBL] [Abstract][Full Text] [Related]
19. Sensitizing of β-lactam resistance by tannic acid in methicillin-resistant S. aureus.
Kırmusaoğlu S
World J Microbiol Biotechnol; 2019 Mar; 35(4):57. PubMed ID: 30900046
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia.
Dhand A; Sakoulas G
Clin Ther; 2014 Oct; 36(10):1303-16. PubMed ID: 25444563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
